mRNA therapeutic

This page covers all mRNA therapeutic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting myostatin.

Targets

myostatin

Marketed (1)

• mRNA · University Hospital Tuebingen · Oncology, Immunology, Infectious Disease, Genetic Disorders
  mRNA-based therapeutics deliver genetic instructions to cells to produce therapeutic proteins or trigger immune responses.

Phase 3 pipeline (1)

• mRNA-1083 · ModernaTX, Inc. · Musculoskeletal
  mRNA-1083 encodes an optimized full-length human myostatin propeptide to inhibit myostatin activity and promote muscle growth.